A synthetic peptide for use as a blocking control in assays to test for specificity of CTTN antibody, Alternative Names: Cortactin control peptide, Cortactin antibody Blocking Peptide, Anti-Cortactin Blocking Peptide, EMS1 Blocking Peptide, FLJ34459 Blocking Peptide, CTTN Blocking Peptide
CTTN is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. CTTN is localized in the cytoplasm and in areas of the cell-substratum contacts. It has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells.